Lisa Dyson, PhD
Chief Executive Officer
Dr. Lisa Dyson has a diverse background in management, business consulting, technology development and scientific research. As a management consultant at The Boston Consulting Group, Dr. Dyson worked with executives of multi-national corporations to develop high-impact strategies and execution plans to expand into new markets, facilitate post-merger integrations, define international governance models, and identify millions of dollars in operational cost inefficiencies. Dr. Dyson has experience in a number of industries, including transportation, travel, automotive, packaging, retail, telecommunications, and energy. In addition, Dr. Dyson enjoys building and leading entrepreneurial teams to develop new technologies. Previous startup experience includes developing a social networking platform that was used in a national election campaign and building a technology that received funding from Microsoft. Dr. Dyson has a strong technical background and has been awarded a number of honors in connection with her technical work. Dr. Dyson has conducted research in Bioengineering and Physics, including energy research, at Stanford University, the University of California, Berkeley, Princeton University, the University of California, San Francisco, the Massachusetts Institute of Technology (MIT), and the Lawrence Berkeley National Laboratories. Dr. Dyson has a PhD in Physics from MIT, where she conducted research in String Theory, was a Fulbright Scholar at the University of London, where she received an MS in Physics with an emphasis in Quantum Fields and Fundamental Forces, and has degrees in Mathematics and Physics from Brandeis University.
John Reed, PhD
Chief Technology Officer
Dr. John Reed is Kiverdi’s Founding CTO and the inventor of our core technology. Dr. Reed is an expert in chemical and biological energy storage and conversion technologies and has over 15 years of experience in the research and development of clean energy technologies. Dr. Reed has a strong multi-disciplinary background in a number of scientific disciplines including biology, physics, material science and applied mathematics. He has conducted research at leading institutions including the Massachusetts Institute of Technology, Lawrence Livermore National Laboratories and Lawrence Berkeley National Laboratories. He has authored more than a dozen articles published in international peer-reviewed journals, has been an invited speaker at scientific conferences including APS and DARPA, and is an inventor on several patent applications, including patent applications on microbial carbon capture. Dr. Reed earned a PhD and an MS degree in Material Science and Engineering from the Massachusetts Institute of Technology as well as degrees in Biology and Material Science from UC Berkeley. He has developed a unique approach to carbon mitigation that is a hybrid chemical and microbial process for the capture and recycling of inorganic carbon into high energy density biofuel and chemicals using conventional bioreactors without reliance on food-based agriculture.
Senior Vice President of Business Development
Guy previously served as President of North American operations for Cognis (now Emery Oleochemicals), overseeing business with productions units in the United States and Canada. Prior to that he served as Vice President and General Manager of the Performance Products Business Group at Cabot Corporation. Guy began his career as the Marketing Director for DSM and then Mobil Chemicals and he has worked more than 25 years in various leadership and executive positions in the chemicals industry, both for commodity and specialty product businesses. He has lived and worked around the world working in plastics, fine particles (pigments, fillers), advanced composite materials for aerospace, specialty compounds, oleochemicals, color/additive concentrate and the renewable energy industries. In addition, Guy currently serves on the board or advisory board of several start-up companies including the multinational Bridging Competencies BV. He has an extensive experience in development and execution of strategy as well as creating customer value, new business growth by collaborating closely with customers and by bringing together the complementary skill sets of companies in business consortia and partnerships. Guy is fluent in four languages and is a native of the Netherlands where he received his BSc in Chemical Engineer and his MBA from the University of Twente.
Itzhak Kurek, PhD
Senior Director of R&D
Dr. Itzhak Kurek has 20 years of experience in metabolic engineering, plant photosynthesis and cellulose biosynthesis. Dr. Kurek joined Kiverdi from DuPont/Pioneer Hi-Bred International, Inc. where he led the improvement of key enzymes in the carbon fixation pathway, by directed evolution and rational design, in agricultural and industrial crops. Dr. Kurek has extensive expertise in developing novel high throughput screenings for enzymatic activity, small molecules detection and protein identification. Dr. Kurek held positions at Maxygen Inc. and Verdia Inc. He received his Ph.D. and M.Sc. in Plant Sciences from Tel Aviv University and completed his postdoctoral research at the University of California, Davis. Dr. Kurek has also conducted research at the Technical University of Munich, John Innes Center Norwich and C.N.R.S Bordeaux. Dr. Kurek has authored 20 publications and is co-inventor on multiple patents in directed evolution and high throughput screening of small molecules. Dr. Kurek is currently also a visiting researcher at the Lawrence Berkeley National Laboratories.
Henrik Fyrst, PhD
Director of Analytical Chemistry
Dr. Henrik Fyrst has more than 15 years of experience in the field of lipid biochemistry. Dr. Fyrst joined Kiverdi from Children’s Hospital Oakland Research Institute where he directed studies on the regulation of lipids and the role of lipid signaling in development and disease. Dr. Fyrst has a strong background in the field of lipid metabolism obtained through studies in simple organisms such as bacteria, yeast, worms and fruit flies as well as in mammalian systems. He has extensive expertise in developing methods for purification and analysis of lipids using HPLC, GC and MS instrumentation. Dr. Fyrst received his Ph.D. and M. Sc. from the University of Southern Denmark, Odense, Denmark, where he studied proteins involved in fatty acid biosynthesis, regulation and transport. He received his post-doctoral training at Children’s Hospital Oakland where he later became an established scientist. Dr. Fyrst has authored more than 20 articles published in international peer-reviewed journals and is the co-inventor of multiple patents.